Key facts
- Embion Technologies’s last known valuation is $28.9M (Dec 2021).
- It has raised $6.5M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Venture Kick, EIT Food, Ecole Polytechnique Federale de Lausanne, Endeavor Greece, 3LB Seed Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Embion Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Embion Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Embion Technologies
Developer of biomass processing technology designed to catalyze the world's transition to zero waste. The company's technology specializes in the novel extraction and composition of plant-based bioactive for human and animal nutrition, enabling clients to accelerate the development of functional nutrition while providing a significant decrease in cost and time-to-market.
- Sector
- Business Products and Services (B2B)
- HQ
- Etoy, Switzerland
- Founded
- 2016
- Employees
- 6
- Website
- embiontech.com/
- Ownership
- Privately Held (backing)
Embion Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Embion Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Embion Technologies in its N-PORT filings yet. We sweep new filings monthly.